Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Haematologica|December 14, 2004
Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantationEva María Villaron, Julia Almeida, Natalia López-Holgado, et al.Cancer|January 28, 2003
Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemiaAna Rasillo, María Dolores Tabernero, María Luz Sánchez, et al.Cytotherapy|November 26, 2009
Prospective comparative analysis of the angiogenic capacity of monocytes and CD133+ cells in a murine model of hind limb ischemiaNatalia López-Holgado, Mercedes Alberca, Fermin Martin Sánchez-Guijo, et al.Haematologica|October 18, 2006
The association of increased p14ARF/p16INK4a and p15INK4a gene expression with proliferative activity and the clinical course of multiple myelomaMaría Eugenia Sarasquete, Ramón García-Sanz, Adriana Armellini, et al.Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|July 8, 2015
Influence of antiplatelet-anticoagulant drugs on the need of blood components transfusion after vesical transurethral resectionAlvaro Julio Virseda-Rodríguez, Barbara Padilla-Fernández, Mirian López-Parra, et al.Haematologica|August 18, 2012
Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipientsJorge Labrador, Lucia Lopez-Anglada, Estefania Perez-Lopez, et al.Hematological Oncology|September 9, 2016
Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism arrayRamón García-Sanz, Luis Antonio Corchete, Miguel Alcoceba, et al.Haematologica|February 12, 2002
Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trialJosep-Maria Ribera, Juan-José Ortega, Albert Oriol, et al.The Lancet. Oncology|August 27, 2010
Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trialMaría-Victoria Mateos, Albert Oriol, Joaquín Martínez-López, et al.Pageof 2